# CAR-NK Therapy for Cardiac Amyloidosis

> **NCT07504289** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 36 (estimated)

## Conditions studied

- Light Chain Cardiac Amyloidosis

## Interventions

- **PROCEDURE:** CAR-NK

## Key facts

- **NCT ID:** NCT07504289
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-07
- **Primary completion:** 2028-03-06
- **Final completion:** 2029-03-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07504289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07504289, "CAR-NK Therapy for Cardiac Amyloidosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07504289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*